Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating on November 8. Graig ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Sarepta Therapeutics is advancing SRP-9003 gene therapy for LGMD, with phase 3 study results expected in early 2025. Learn ...

Sangamo Therapeutics ranks at the bottom for Revenue Growth and Gross Profit, indicating lower performance compared to its peers. However, it ranks in the middle for Return on Equity, suggesting ...

Several key players are shaping the global pruritus therapeutics market. Companies such as Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical ...

As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low. The consumer price index ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

We intend to achieve our goals with a high-performing team committed to execute, focus and innovate to drive our continued growth and long-term transformation ... To report SUSPECTED ADVERSE REACTIONS ...